Show Summary Details
Page of

Clinical presentation and assessment of disease activity in lupus nephritis 

Clinical presentation and assessment of disease activity in lupus nephritis
Chapter:
Clinical presentation and assessment of disease activity in lupus nephritis
Author(s):

Venkat Reddy

and David Isenberg

DOI:
10.1093/med/9780199579655.003.0010
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 April 2020

1. There is renal involvement in 35–75% of patients with SLE.

2. Relatively few patients develop renal failure and failure of treatment compliance is often a major contributory factor.

3. Defining whether renal abnormalities are due to activity, damage or a combination of both is important in guiding treatment.

4. General activity indices such as the BILAG or SLEDAI scoring systems, together with more specific indicators (e.g. PCR and the presence of urinary red cells and casts) provide an optimal way of assessing disease activity in a patient with lupus nephritis.

5. Renal biopsy remains an essential ‘tool’ in determining the type of lupus involvement, the degree of activity and damage, and the outcome.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.